References

  • Bill and Melinda Gates Foundation (2014) Methods for Economic Evaluation Project (MEEP) The Gates Reference Case.
  • Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’Brien, B. and Stoddart, G. L. (2005) Methods for the Economic Evaluation of Health Care Programmes 3ed., Oxford University Press.
  • Drummond, M. F. and Jefferson, T. O. (1996) 'Guidelines for authors and peer reviewers of economic submissions to the BMJ', BMJ, 313(7052), 275-283.
  • Global Heath Cost Consortium (2017) ‘The Reference Case for Global Health Costing’, [online], Available from: https://ghcosting.org/pages/standards/reference_case   [Accessed 13 June 2017]
  • Gold, M. R., Siegel, J. E., Russell, L. B. and Weinstein, M. C. (1996) Cost-effectiveness in health and medicine, Oxford University Press.
  • Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., et al. (2013) 'Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement', BMJ : British Medical Journal, 346.
  • Neumann, P. J., Stone, P. W., Chapman, R. H., Sandberg, E. A. and Bell, C. M. (2000) 'The quality of reporting in published cost-utility analyses, 1976–1997', Annals of Internal Medicine, 132(12), 964-972.
  • Pharmaceutical Benefits Advisory Committee (2016) Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (version 5.0), Australian Government Department of Health.
  • Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., et al. (2015) 'Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report', Value in Health, 18(2), 161-172.
  • Sullivan, S. M., Wells, G. and Coyle, D. (2015) 'What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic Review', Value Health, 18(6), 915-24.
  • Thai Health Technology Assessment Guideline Working Group (2008) 'Guidelines for Health Technology Assessment in Thailand (First Edition)'.